Table 2

Morbidity and health services usage data and percentages of pregnant women receiving folic acid and iron
Na (%) % Receiving folic acid (n = 3,758) Chi square p-value % Receiving Iron (n = 4,887) Chi square p-value % Receiving iron +  folate (n = 3,508) Chi square p-value
Before pregnancy
Malaria
Y 12,605 (57.6) 12.8 *** 20.4 *** 11.7 ***
N 9,284 (42.4) 23.1 25.0 21.9
Other diseases before pregnancy
Y 3,795 (17.3) 10.0 *** 19.6 *** 8.7 ***
N 18,094 (82.7) 18.7 22.9 17.6
HIV
Y 795 (3.8) 18.0 *** 26.4 ** 16.6 ***
N 11,059 (43.5) 14.8 21.5 13.4
Status unknown 10,035 (52.7) 19.7 22.9 18.9
During pregnancy
Parity
First child 8,595 (39.3) 20.3 *** 26.5 *** 18.8 ***
Not first child 13,294 (60.8) 15.1 19.6 14.2
Antenatal care during pregnancy
Y 21,658 (98.9) 17.2 *** 22.4 *** 11.9 ***
N 160 (0.7) 12.5 15.6 16.1
Number of antenatal care visits
“0-1” 502 (2.4) 14.5 * 18.5 13.1 *
“2-3” 5017 (23.6) 15.9 14.9 14.9
“4-8” 14387 (67.6) 17.6 16.4 16.4
“9-15” 1392 (6.5) 18.0 20.5 16.6
Preeclampsia/Eclampsia
Y 8881 (4.0) 10.2 *** 12.5 8.5 ***
N 21,008 (96.0) 17.5 22.7 16.3
Anaemia
Y 471 (2.2) 70.1 *** 74.9 *** 65.8 ***
N 21,418 (97.9) 16.0 21.2 14.9
Malaria
Y 4,465 (20.4) 11.1 *** 14.3 10.2 ***
N 17,424 (79.6) 18.7 24.4 17.5
Infections
Y 8,924 (40.8) 12.2 *** 15.6 10.7 ***
N 12,965 (59.2) 20.6 27.0 19.7
Other diseases during pregnancy
Y 1,074 (4.9) 11.0 *** 13.7 9.0 ***
N 20,815 (95.1) 17.5 22.8 16.4

Northern Tanzania 1999-2008.

* p < 0.05.

** p < 0.01.

*** p < 0.001.

aThe numbers do not add to the total due to missing values.

Ogundipe et al.

Ogundipe et al. BMC Public Health 2012 12:481   doi:10.1186/1471-2458-12-481

Open Data